Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.380
-0.120 (-2.67%)
Mar 27, 2026, 4:00 PM EDT - Market closed

Bolt Biotherapeutics Revenue

In the year 2025, Bolt Biotherapeutics had annual revenue of $7.70M with 0.07% growth. Bolt Biotherapeutics had revenue of $2.50M in the quarter ending December 31, 2025.

Revenue (ttm)
$7.70M
Revenue Growth
+0.07%
P/S Ratio
1.09
Revenue / Employee
$192,375
Employees
40
Market Cap
8.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.70M5.00K0.07%
Dec 31, 20247.69M-186.00K-2.36%
Dec 31, 20237.88M2.15M37.48%
Dec 31, 20225.73M4.47M354.68%
Dec 31, 20211.26M1.03M445.45%
Dec 31, 2020231.00K16.00K7.44%
Dec 31, 2019215.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition